Peer-reviewed scientific e-poster: "Performances of an End-to-End AI/ML CADe/CADx SaMD for Nodule Detection and Characterization in Lung Cancer Screening on an Independent Cohort Compared to...
Pursuant to article L-223-8 II of the French “code de Commerce” and 223-16 of the AMF’s General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares 18,516,983...
Two globally leading pulmonologists reviewed REALITY data, AI and the potential impact on lung cancer screening Replay in English is available on the link here A French subtitled replay will be...
Webinar to focus on the eyonis™ Lung Cancer Screening (LCS) REALITY data November 7, 2024 – 1:30 pm CET / 7:30 am ET – Registration link Regulatory News: Median Technologies (FR0011049824...
eyonis™ LCS pivotal REALITY study met all primary and secondary endpoints A webcast including Key Opinion Leaders will be held on November 7, 2024, to discuss the REALITY study results On track...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.48 | -13.7931034483 | 3.48 | 3.48 | 2.91 | 86943 | 3.12483872 | DE |
4 | -0.99 | -24.8120300752 | 3.99 | 4.44 | 2.91 | 81165 | 3.67710991 | DE |
12 | -1.53 | -33.7748344371 | 4.53 | 4.86 | 2.91 | 113463 | 4.09885978 | DE |
26 | -0.62 | -17.1270718232 | 3.62 | 7.76 | 2 | 154147 | 4.71323396 | DE |
52 | -0.845 | -21.9765929779 | 3.845 | 7.76 | 2 | 99807 | 4.44549911 | DE |
156 | -12.08 | -80.1061007958 | 15.08 | 16.66 | 2 | 51485 | 6.15704268 | DE |
260 | 1.4 | 87.5 | 1.6 | 18.32 | 0.94 | 61037 | 6.85181593 | DE |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約